XML 30 R20.htm IDEA: XBRL DOCUMENT v3.25.1
Subsequent Events (Notes)
3 Months Ended
Mar. 31, 2025
Subsequent Event [Line Items]  
Subsequent Events [Text Block] Subsequent Events
The company has evaluated subsequent events through the date the financial statements were issued. On April 14, 2025, S&P Global and CME Group announced the signing of a definitive agreement to sell OSTTRA, our 50% equity method investment, to investment funds managed by KKR & Co. Inc. OSTTRA is a provider of post-trade solutions for the OTC market. The carrying amount of the company's investment in OSTTRA was $1.2 billion including approximately $100.0 million of accumulated foreign currency translation adjustments at March 31, 2025. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, subject to customary purchase price adjustments, which will be divided evenly between S&P Global and CME Group pursuant to the 50/50 joint venture. The transaction is expected to close in the second half of 2025, subject to customary closing conditions and receipt of required regulatory approvals.